Volumina Medical Gets a CHF 500 000 Loan from FIT
Share this article
Volumina Medical is an EPFL spin-off based in Biopôle Lausanne. The company develops a biogel that supports the repair of soft tissues.
Volumina Medical is developing highly innovative biomaterials for regenerative medicine. Their solutions address high unmet needs for the markets of reconstructive and plastic surgery. Volumina’s first product is Adipearl, a leading innovative biomaterial being developed to support the repair of soft tissues, initially targeting breast reconstruction after cancer surgery.
Each year, around 2 million women are diagnosed with breast cancer worldwide, 500’000 of whom are in Europe. These patients increasingly resort to reconstructive surgeries to regain their natural and healthy physical appearance. Unfortunately, today, the available techniques are either too burdensome, induce long-term foreign body reactions, require repeated surgeries or do not bring durable results. In addition, a high number of patients are not eligible for one of these techniques and remain untreated.
To address this significant unmet medical need, Volumina Medical has been working for several years on the development of a platform of novel injectable biomaterials to support soft tissue repair. The lead product from this work is Adipearl which has gone through extensive pre-clinical studies and is now being tested in patients. The first therapeutic target is breast reconstruction following cancer surgery.
Thanks to the Foundation for Technological Innovation loan, Volumina Medical will conduct a first in human clinical study in Europe.
Source: Press Release